A cubic-phase oral drug delivery system for controlled release of AG337

Drug Development and Industrial Pharmacy

Volumn 22, Issue 7, 1996, Pages 603-608

  Longer, Mark ^a   Tyle, Praveen ^a   Mauger, John W ^b,c  

^a AGOURON PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NOLATREXED; THYMIDYLATE SYNTHASE INHIBITOR;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; SUSTAINED RELEASE PREPARATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0030055295     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049609063214     Document Type: Article

References (3)

1. K. Larson, Cubic lipid-water phases: structures and biomembrane aspects, J. Phys. Chem., 93, 7304-7314 (1989).
2. P. Tyle, Liquid crystals and their applications in drug delivery, in Controlled Release of Drugs: Polymers and Aggregate Systems (M. Rosoff, ed.), VCH, New York, 1990, pp. 125-162.
3. D. M. Wyatt and D. Dorschel, A cubic-phase delivery system composed of glyceryl monooleate and water for sustained release of water-soluble drugs, Pharm. Tech., 16, 116-130 (1992).